CBLL (CeriBell) Piotroski F-Score: N/A (As of Jun. 25, 2026)


CBLL CeriBell Inc CBLL
12 GF Score
Price $18.61
! 3 Warning Signs
View Full Analysis

What is CeriBell Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

CeriBell has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for CeriBell's Piotroski F-Score or its related term are showing as below:

During the past 4 years, the highest Piotroski F-Score of CeriBell was 5. The lowest was 4. And the median was 5.

CeriBell  (NAS:CBLL) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


CeriBell Piotroski F-Score Related Terms


CeriBell Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for CeriBell's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CeriBell Piotroski F-Score Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
N/A N/A N/A 4.00

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 5.00 N/A 4.00 N/A

CBLL vs LMRI, SIBN, CERS: Piotroski F-Score Comparison

For the Medical Devices subindustry, CeriBell's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CeriBell Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CeriBell's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where CeriBell's Piotroski F-Score falls into.


CBLL
12GF Score
CeriBell Inc CBLL
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -13.643 + -13.465 + -13.527 + -19.737 = $-60.37 Mil.
Cash Flow from Operations was -7.533 + -11.098 + -10.774 + -19.297 = $-48.70 Mil.
Revenue was 21.199 + 22.589 + 24.784 + 26.494 = $95.07 Mil.
Gross Profit was 18.682 + 19.942 + 21.643 + 23.122 = $83.39 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(213.471 + 207.689 + 199.525 + 195.803 + 178.078) / 5 = $198.9132 Mil.
Total Assets at the begining of this year (Mar25) was $213.47 Mil.
Long-Term Debt & Capital Lease Obligation was $20.98 Mil.
Total Current Assets was $168.91 Mil.
Total Current Liabilities was $16.18 Mil.
Net Income was -8.941 + -10.417 + -12.576 + -12.777 = $-44.71 Mil.

Revenue was 15.315 + 17.195 + 18.534 + 20.491 = $71.54 Mil.
Gross Profit was 13.159 + 15.011 + 16.238 + 18.007 = $62.42 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(0 + 53.176 + 47.059 + 225.412 + 213.471) / 5 = $134.7795 Mil.
Total Assets at the begining of last year (Mar24) was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $20.64 Mil.
Total Current Assets was $205.42 Mil.
Total Current Liabilities was $11.83 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

CeriBell's current Net Income (TTM) was -60.37. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

CeriBell's current Cash Flow from Operations (TTM) was -48.70. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-60.372/213.471
=-0.28281125

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-44.711/0
=

CeriBell's return on assets of this year was -0.28281125. CeriBell's return on assets of last year was . ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

CeriBell's current Net Income (TTM) was -60.37. CeriBell's current Cash Flow from Operations (TTM) was -48.70. ==> -48.70 > -60.37 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=20.975/198.9132
=0.105448

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=20.641/134.7795
=0.15314644

CeriBell's gearing of this year was 0.105448. CeriBell's gearing of last year was 0.15314644. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=168.911/16.184
=10.436913

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=205.42/11.831
=17.36286028

CeriBell's current ratio of this year was 10.436913. CeriBell's current ratio of last year was 17.36286028. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

CeriBell's number of shares in issue this year was 37.663. CeriBell's number of shares in issue last year was 35.881. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=83.389/95.066
=0.87716955

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=62.415/71.535
=0.87250996

CeriBell's gross margin of this year was 0.87716955. CeriBell's gross margin of last year was 0.87250996. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=95.066/213.471
=0.4453345

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=71.535/0
=

CeriBell's asset turnover of this year was 0.4453345. CeriBell's asset turnover of last year was . ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+0+0+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

CeriBell has an F-score of 5 indicating the company's financial situation is typical for a stable company.


CeriBell Business Description

Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score

Get the complete analysis for CBLL

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.61
Price